Search Results 411-420 of 9231 for 磁力搜索引擎咨询邮箱:lgooxc@hotmail.com
Contact Mayo Clinic study team members and support staff with questions about clinical studies.
The atezolizumab plus obinutuzumab) (Arm E) will enroll participants with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
Lee, Jeong-Heon Ph.D. lee.jeongheon@mayo.edu; Assistant Professor of Biochemistry and Molecular Biology; Publications. Narayanan, Sathiya Pandi Ph.D.
Contact the Hospital Experiences to Advance Goals and Outcomes Network (HEXAGON) at Mayo Clinic with questions about research resources or collaboration.
Sandra C. Bryant supports the development of reference ranges in the Department of Laboratory Medicine and Pathology as well as many research projects by its ...
A Study to Evaluate the Effectiveness and Safety of Pemigatinib in Previously-treated, Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor ...
The purpose of this study is to assess the combined impact of post-processing methods that quantify potential biomarkers of chronic liver disease (AEF, fECS) ...
Learn how to request an extension for Benefactor-Funded Research Established-Investigator Career Awards at Mayo Clinic's Center for Clinical and ...
About this study. The overall objective is to develop a clinical data registry that can be used to facilitate research with the ultimate goal of reducing ...
This study will evaluate the long term efficacy, safety, and tolerability of repeated administration of adalimumab in subjects with Crohn's disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.